Hypertension Clinical Trial
Official title:
Beneficial Effects of Pork Bioactive Peptides on Cardiovascular Health in Humans
Spanish dry-cured ham has been shown a source of antihypertensive peptides in mice. To date,
no clinical study has been performed in humans to check the effects of bioactive peptides
produced naturally during the processing of pork dry-cured ham on blood pressure. Therefore,
the aim of the present study is to investigate whether consuming peptides from cured pork
ham with demonstrated angiotensin I-converting enzyme (ACE) inhibitory activity lowers blood
pressure (BP) and improves other risk factors for cardiovascular disease (CVD).
Objectives: To demonstrate the lowering effects of bioactive peptides from cured pork ham
with >10 months dry-curing process in humans. To check for other possible benefits related
to dry-cured ham intake such as: platelet activation and cardiovascular risk factors.
A two-arm cross-over clinical study with a diet control will be assessed at the Catholic
University of Murcia (UCAM).
A recruitment of 50 volunteers will be attempted in order to fulfil the UCC calculations.
The 50 patients will be divided into two groups (25 vs 25). One group will receive dry-cured
pork ham of >10 months proteolysis (intervention product) while the other will receive
cooked, uncured ham (control product), each for one month. After two weeks wash out, the
groups will be exchanged for one additional month. In this way, each group will take cooked
ham and dry-cured pork ham for 28 days each arm.
Pork hams Two pork hams from the same raw meat will be used in the present study: dry-cured
pork ham with >10 months dry-curing process as the intervention product and cooked, uncured
ham as the control product. Both products will be purchased in vacuum bags and labelled with
safety information (expiration date, nutritional composition and storage information).
Dry-cured ham with reduced salt will be used in order to decrease the sodium intake that
could affect BP too. Such ham contains 25% lower salt than similar products on the market
(3,7g vs 4,5g/100g) (see leaflet of a possible ham enclosed).
Dry-cured ham (80g) will be taken daily by the volunteers (50% humidity); BP will be
measured as follows. In order to counteract the higher water contain (70% humidity), a
higher amount of cooked ham will be given to the control groups (100g). Besides, cooked ham
contains 2.5g salt/100g which is in relation with the 2,96g salt/80g reduced salt dry-cured
ham. A restriction list food will be also given to the volunteers in order to control salt
intake.
Volunteers Caucasian men and women, aged 35-60 years, in good general health with an average
of systolic arterial pressure >130 mmHg and diastolic > 80 mmHg will be recruited. Exclusion
criteria are: smokers, Diabetes mellitus, diagnosed and treated hypertension, history of
cardiovascular events (stroke, myocardial infarction or peripheral vascular disease),
medications: anti-hypertensives, vasodilators, lipid lowering therapies and fish oil
supplements unless willing to discontinue prior to and during study (all other supplements
will be assessed on a case by case basis).
Weight, height, body mass index and waist circumference will be measured at the beginning of
the study by qualified nurses. A list of restricted food will be given at the beginning of
the study in order to avoid excessive salt consumption.
Besides, three 24h intake surveys will be conducted for three no consecutive days (one of
them on Sunday) during the study. Another survey regarding their diet habits and salt intake
will be also conducted three times, once with each ham and in wash out period.
Blood pressure measurements Blood pressure will be measured with two different approaches:
24h ambulatory monitoring of BP.
24h ambulatory monitoring. A 24h recording will be assessed to all the volunteers included
in the study at four different time points (before/after control product and before/after
intervention product). Volunteers will be appointed for a blood extraction and a digital
manometer device OMRON M24/7 BP5 properly calibrated will be installed to each volunteer.
Home auto-monitoring of BP. Auto-measurement of BP will be performed following the
recommendations of the Spanish Society of Hypertension, Spanish League Against Hypertension
(SEHLELHA) and the European Society of Hypertension (ESH) three times during each
intervention. On the day of first appointment at the doctor office, individuals will be
taught how to auto-measure its BP at home and the dominant arm will be determined. A digital
manometer device OMROM 705CP properly calibrated will be given to each volunteer for a short
period of time. BP will be measured 3 times during each interventional product (cured pork
ham and cooked ham) as follows. The three different days, the volunteer will be asked to
measure three times per day (before breakfast, 2h after pork consumption —preferably before
lunch— and before dinner), and each measurement will be repeated for three times, about one
minute apart. The volunteer will measure its BP seated after resting 5 min in this position,
he will not smoke, ingest food or caffeine beverages (coffee, tea or colas), or exercise
(including stair climbing) in the previous 30 minutes prior to the time of measurement.
Measurements will be done in the dominant arm. The systolic and diastolic blood pressure
readings will be recorded. The mean of the three measures will be used for all analyses.
Biochemical parameters Blood will be taken before each phase (cured pork ham/cooked ham) and
after the end of such intakes, following by a 2 weeks wash out period (total 4 time points).
Blood analysis will be performed after fasting for at least 8 hours.
Blood lipid profile (total cholesterol, HDL, LDL and triglycerides); hemogram, plasma
glucose, creatinine, albumin and uric acid will be measured.
Plasma will be collected and stored at -80ºC for further analysis such as C reactive
protein, fibrinogen and interleukins if the case.
Participants will be asked to provide a 24-hour urine collection and they will be given
written and verbal instructions for the 24-hour collection. The first urine of the day will
be discarded and all urine over the following 24 hours will be collected in standard
containers that will be provided. Total volume of the collection will be measured by the
volunteers. Urine collections will be rejected if 24-hour urinary volumes were less than 250
mL, or if the timing of the collection fell outside the range of 20-28 hours. In accordance
with the standard procedure, urinary sodium and potassium will be measured using ion
selecting electrode method.
Daily salt intake will be estimated based on calculation of 24-hour urinary sodium excretion
on the assumption that all sodium ingested was in the form of sodium chloride.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |